FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia.

We were interested in the recent report by Kelly et al[1][1] that FLT3 internal tandem duplication (FLT3-ITD) mutations, while sufficient to induce a chronic myeloproliferative disease in a murine bone marrow transplant (BMT) assay, were not sufficient to induce an acute myeloid leukemia (AML)